Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMSAM in Adolescents with Major Depression
NCT00531947Phase 4Completed
- Sponsor
- Somerset Pharma
- Start
- Jul 2007
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing EMSAM with Placebo (2 arms). Primary endpoint: Children's Depression Rating Scale-Revised Total Score (Child) at 12 weeks. Started Jul 2007; status: completed.
02
Drugs
selegiline transdermal patch
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00531947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00531947.